Table 2 Correlations of HOMA-IR with clinical and biochemical variables.

From: Risk factors for insulin resistance related to polycystic ovarian syndrome in Iranian population

Variables

r coefficient

p-value

Age (years)

0.045

0.619

Acne score

0.037

0.681

Hirsutism score

− 0.034

0.707

BMI (kg/m2)

0.400

 < 0.001

Fat percent (%)

0.437

 < 0.001

Fat mass (kg)

0.437

 < 0.001

FFM (kg)

0.270

0.002

Waist circumference (cm)

0.418

 < 0.001

Systolic blood pressure (mmHg)

0.165

0.068

Diastolic blood pressure (mmHg)

0.145

0.108

FSH (mIU/mL)

0.043

0.632

LH (mIU/mL)

0.063

0.482

LH/FSH ratio

0.057

0.530

Testosterone (ng/mL)

0.051

0.569

FAI

0.286

0.001

DHEA (ng/dL)

− 0.018

0.841

SHBG (nmol/L)

− 0.312

 < 0.001

hs-CRP (mg/L)

0.238

0.008

Fasting insulin (uIU/mL)

0.970

 < 0.001

C-peptide (ng/mL)

0.512

 < 0.001

FBS (mg/dL)

0.451

 < 0.001

HbA1c (%)

0.130

0.153

AST (U/L)

0.125

0.166

ALT (U/L)

0.260

0.003

Total cholesterol (mg/dL)

0.125

0.165

HDL-cholesterol (mg/dL)

− 0.055

0.546

LDL-cholesterol (mg/dL)

0.114

0.206

Triglycerides (mg/dL)

0.332

 < 0.001

Cr (mg/dL)

− 0.037

0.680

  1. Significant values are in bold.
  2. HOMA-IR homeostasis model assessment insulin resistance, BMI body mass index, FSH follicle-stimulating hormone, LH luteinizing hormone, FAI free androgen index, DHEA Dehydroepiandrosterone, SHBG Sex hormone-binding globulin, hs-CRP high-sensitivity C-reactive protein, FBS fasting blood sugar, HbA1c hemoglobin A1c, AST aspartate aminotransferase, ALT alanine aminotransferase, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, Cr creatinine.